Barry Jacobson to South Africa
This is a "connection" page, showing publications Barry Jacobson has written about South Africa.
Connection Strength
0,599
-
Not so rare: It's time to raise awareness of rare diseases in South Africa. S Afr Med J. 2022 02 02; 112(1):13522.
Score: 0,078
-
Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. S Afr Med J. 2022 02 02; 112(1):13518.
Score: 0,078
-
Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia. S Afr Med J. 2021 04 20; 111(6):535-537.
Score: 0,074
-
Thrombosis - prevention is better than cure. S Afr Med J. 2013 Feb 15; 103(4):231.
Score: 0,042
-
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost. 2010 Dec; 104(6):1228-34.
Score: 0,036
-
At last--the end of the prothrombin index. S Afr Med J. 2007 Dec; 97(12):1271.
Score: 0,029
-
Anticoagulation in South Africa--a dangerous necessity. S Afr Med J. 2006 Aug; 96(8):694.
Score: 0,027
-
Anticoagulant therapy in pregnant women with mechanical and bioprosthetic heart valves. Int J Gynaecol Obstet. 2025 Mar; 168(3):1017-1025.
Score: 0,024
-
In vitro effects of thawing fresh-frozen plasma at various temperatures. Clin Appl Thromb Hemost. 2004 Apr; 10(2):143-8.
Score: 0,023
-
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024 Feb 27; 42(6):1195-1199.
Score: 0,022
-
A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE. Clin Appl Thromb Hemost. 2023 Jan-Dec; 29:10760296231160748.
Score: 0,021
-
Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist? J Clin Apher. 2022 Oct; 37(5):460-467.
Score: 0,020
-
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022 06; 19(6):e1004024.
Score: 0,020
-
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
Score: 0,020
-
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study. N Engl J Med. 2021 08 05; 385(6):570-571.
Score: 0,019
-
Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease. Int J Gynaecol Obstet. 2019 Apr; 145(1):70-75.
Score: 0,016
-
Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS One. 2018; 13(10):e0204899.
Score: 0,016
-
Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients. Transfusion. 2016 Oct; 56(10):2631-2636.
Score: 0,013
-
Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events. J Neurol Sci. 2009 Feb 15; 277(1-2):80-2.
Score: 0,008
-
Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost. 2008 Jul; 14(3):352-5.
Score: 0,007
-
Thrombo-embolic and bleeding complications in patients with mechanical valve replacements--a prospective observational study. S Afr Med J. 2006 Aug; 96(8):710-3.
Score: 0,007